A.L. Sutterland MD publications

2021

• Hagen Julia M., Sutterland Arjen L., Liefers Tessa, Schirmbeck Frederike, Cohn Danny M., Lok Anja, Tan Hanno L., Zwinderman Aeilko H., de Haan Lieuwe Skin autofluorescence of advanced glycation end products and mortality in affective disorders in the lifelines cohort study: A mediation analysis Journal of affective disorders 2021;282:1082-1089

2020

• Hagen Julia M., Sutterland Arjen L., Edrisy Sarah, Tan Hanno L., de Haan Lieuwe Accumulation rate of advanced glycation end products in recent onset psychosis: A longitudinal study Psychiatry research 2020;291 [PubMed]
• Çakici Nuray, Sutterland Arjen L., Penninx Brenda W. J. H., Dalm Virgil A., de Haan Lieuwe, van Beveren Nico J. M. Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis Brain, behavior, and immunity 2020;88:547-558 [PubMed]
• Wezenberg Babet N., Hagen Julia M., Sutterland Arjen L., Schrantee Anouk, de Haan Lieuwe Association between Advanced Glycation End products and brain volumes in recent onset psychosis Schizophrenia research 2020;224:181-182 [PubMed]
• Hagen Julia M., Sutterland Arjen L., da Fonseca Pereira de Sousa Paulo A. L., Schirmbeck Frederike, Cohn Danny M., Lok Anja, Tan Hanno L., Zwinderman Aeilko H., de Haan Lieuwe Association between skin autofluorescence of advanced glycation end products and affective disorders in the lifelines cohort study Journal of affective disorders 2020;275:230-237 [PubMed]
• Xu Fei, Ma Xinyu, Zhu Yuwei, Sutterland Arjen, Cheng Ruitang, Miao Sunhan, Chen Jialu, Qiu Liying, Zhou Yonghua Effects of Toxoplasma gondii infection and schizophrenia comorbidity on serum lipid profile: A population retrospective study from Eastern China Microbial pathogenesis 2020;149 [PubMed]
• Nieman Dorien H., Chavez-Baldini UnYoung, Vulink Nienke C., Smit Dirk J. A., van Wingen Guido, de Koning Pelle, Sutterland Arjen L., Mocking Roel J. T., Bockting Claudi, Verweij Karin J. H., Lok Anja, Denys Damiaan Protocol Across study: longitudinal transdiagnostic cognitive functioning, psychiatric symptoms, and biological parameters in patients with a psychiatric disorder BMC psychiatry 2020;20 (1):212 [PubMed]
• Çakici Nuray, Sutterland Arjen L., Penninx Brenda W. J. H., de Haan Lieuwe, van Beveren Nico J. M. Reply to interleukin-6 in schizophrenia: Cause of death matters Brain, behavior, and immunity 2020;90:383-384 [PubMed]
• van de Giessen Elsmarieke, Sutterland Arjen L., van der Pluijm Marieke, Becker Hiske E., de Haan Lieuwe Shortening Duration of Treatment Resistance: The Next Step in the Treatment of Schizophrenia Schizophrenia bulletin 2020
• Hagen Julia M., Sutterland Arjen L., Schirmbeck Frederike, Cohn Danny M., Lok Anja, Tan Hanno L., Zwinderman Aeilko H., de Haan Lieuwe Skin autofluorescence of advanced glycation end products and course of affective disorders in the lifelines cohort study, a prospective investigation Journal of affective disorders 2020;276:424-432 [PubMed]

2019

• Vermeulen Jentien M, van Rooijen Geeske, van de Kerkhof Marita P J, Sutterland Arjen L, Correll Christoph U, de Haan Lieuwe Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years Schizophrenia bulletin 2019;45 (2):315-329 [PubMed]
• Sutterland Arjen L., Kuin Anne, Kuiper Bouke, van Gool Tom, Leboyer Marion, Fond Guillaume, de Haan Lieuwe Driving us mad: the association of Toxoplasma gondii with suicide attempts and traffic accidents - a systematic review and meta-analysis Psychological medicine 2019;49 (10):1608-1623 [PubMed]
• Sutterland Arjen L., Blom Marieke T., Ladee Katinka, Lubbers Jorieke J. M., Cohen Dan, de Haan Lieuwe, Tan Hanno L. Increased prevalence of ECG suspicious for Brugada Syndrome in recent onset schizophrenia spectrum disorders Schizophrenia research 2019;210:59-65 [PubMed]
• van der Pluijm Marieke, Sutterland Arjen L, van Kuilenburg André B P, Zoetekouw Lida, de Haan Lieuwe, Booij Jan, van de Giessen Elsmarieke Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients Therapeutic advances in psychopharmacology 2019;9 [PubMed]
• Snijders Gijsje J. L. J., van Mierlo Hans C., Boks Marco P., Begemann Marieke J. H., Sutterland Arjen L., Litjens Manja, Ophoff Roel A., Kahn René S., de Witte Lot D. The association between antibodies to neurotropic pathogens and bipolar disorder: A study in the Dutch Bipolar (DB) Cohort and meta-analysis Translational psychiatry 2019;9 (1) [PubMed]

2017

• Hagen Julia M., Sutterland Arjen L., Koeter Maarten W., Lutter Rene, Cohen Dan, de Haan Lieuwe Advanced Glycation End Products in Recent-Onset Psychosis Indicate Early Onset of Cardiovascular Risk Journal of clinical psychiatry 2017;78 (9):1395-1401 [PubMed]

2016

• van der Doef Thalia F., de Witte Lot D., Sutterland Arjen L., Jobse Ellen, Yaqub Maqsood, Boellaard Ronald, de Haan Lieuwe, Eriksson Jonas, Lammertsma Adriaan A., Kahn René S., van Berckel Bart N. M. In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis NPJ schizophrenia 2016;2:16031 [PubMed]

2015

• Sutterland A. L., Fond G., Kuin A., Koeter M. W. J., Lutter R., van Gool T., Yolken R., Szoke A., Leboyer M., de Haan L. Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis Acta psychiatrica Scandinavica 2015;132 (3):161-179 [PubMed]

2014

• Jagt Yara Q., Sutterland Arjen L., Meijer Julia H., Oudijn Marloes S., Kemperman Patrick M., Vulink Nienke C. C., de Haan Lieuwe Parasieten- of infestatiewaan: een therapeutische uitdaging Nederlands tijdschrift voor geneeskunde 2014;158:A7548 [PubMed]

2013

• Sutterland Arjen L., Dieleman Jeanne, Storosum Jitschak G., Voordouw Bettie A. C., Kroon Jojanneke, Veldhuis Joris, Denys Damiaan A. J. P., de Haan Lieuwe, Sturkenboom Miriam C. J. M. Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study Social psychiatry and psychiatric epidemiology 2013;48 (9):1357-1365 [PubMed]
• Kroon Jojanneke S., Wohlfarth Tamar D., Dieleman Jeanne, Sutterland Arjen L., Storosum Jitschak G., Denys Damiaan, de Haan Lieuwe, Sturkenboom Mirjam C. J. M. Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study Bipolar disorders 2013;15 (3):306-313 [PubMed]

2011

• Nieman D. H., Sutterland A. L., Otten J., Becker H. E., Drent M. L., van der Gaag M., Birchwood M., de Haan L. Treating prolactinoma and psychosis: medication and cognitive behavioural therapy BMJ case reports 2011;2011:bcr0720103185 [PubMed]